genia tagger: 243('all', 41)
('shrna', 48)
('brca1-mutated', 8)
('control', 56)
('probe', 6)
('-cgacaagaccccatcgaatgccttttc-3', 2)
('fpg-induced', 2)
('325', 2)
('0\\.0003', 14)
('human', 11)
('ribosomal', 2)
('primer', 2)
('adp-ribose', 4)
('isogenic', 14)
('-gtatggacactgactcaga-3', 2)
('76', 2)
('odd-specific', 10)
('ber-defective', 2)
('23', 12)
('pcr', 12)
('\\?', 93)
('\\<', 16)
('non-dividing', 4)
('3', 240)
('0', 535)
('enzyme', 13)
('horseradish', 2)
('oxidatively-damaged', 8)
('\\.', 864)
('triple-negative', 34)
('suppressor', 3)
('\\(', 451)
('\\)', 463)
('assay', 92)
('greater', 30)
('her2\\/neu', 3)
('coding', 6)
('rna', 61)
('brca2-deficient', 1)
('mdamb468', 14)
('tails', 10)
('breast', 210)
('265', 2)
('129', 2)
('secondary', 2)
('mmecs', 46)
('puromycin\\.', 2)
('and', 534)
('bar', 8)
('58', 8)
('deficient', 30)
('proteins', 5)
('mcf7', 86)
('progesterone', 2)
('receptor-', 2)
('p', 1671)
('lines\\.', 10)
('2a', 22)
('2b', 6)
('-cgatgttgttgttggaggaac-3', 2)
('t47d\\.', 2)
('192', 2)
('-tgccaaagtagctaatgta-3', 2)
('luminal', 60)
('gfp', 92)
('parp-1', 1)
('700', 2)
('t47d', 14)
('900nm', 2)
('brca1\\.', 10)
('177', 2)
('individual', 4)
('49', 38)
('her2', 7)
('bacterial', 2)
('odd', 149)
('87', 2)
('susceptibility', 6)
('er', 1162)
('oncogene', 2)
('antibody\\.', 2)
('hcc1500', 8)
('parental', 2)
('cell', 427)
('contained', 8)
('mcf7shogg1-a', 22)
('hcc1937', 8)
('template', 2)
('mcf7shogg1-b', 22)
('367', 2)
('photodynamic', 2)
('ner', 16)
('\xc2\xb1', 92)
('genes', 22)
('reporter', 42)
('hogg1-knockdown', 16)
('-ggctagacctccaagatca-3', 2)
('mdamb231', 8)
('mdamb436', 8)
('-ggagatcagccattaatat-3', 2)
('parp', 73)
('20', 13)
('g\\/ml', 2)
('reaction', 4)
('39', 2)
('38', 24)
('brca1-deficient', 13)
('r2', 17)
('fig\\.', 82)
('treated', 16)
('pdt', 8)
('37', 14)
('tumor', 10)
('figures', 2)
('comet', 40)
('gene', 101)
('antibody', 4)
('hogg1-', 70)
('\\/sub', 4)
('repair', 97)
('cancer', 192)
('each', 45)
('egfr', 1)
('primary', 2)
('poly', 7)
('29', 8)
('hcc38', 20)
('63', 2)
('receptor', 4)
('0\\.0981', 2)
('wild-type', 36)
('table', 30)
('mcf12a', 8)
('total', 2)
('hcc1143', 18)
('100', 6)
('pr', 316)
('taqman\xc2\xae', 2)
('brca1-', 26)
('gfp-reporter', 8)
('glycosylase', 7)
('250nm', 2)
('anti-tata', 2)
('construct', 2)
('1a', 22)
('2', 502)
('basal-like', 113)
('10ng', 2)
('6', 133)
('mcf7shctrl', 20)
('ber-compromised', 6)
('500', 10)
('brca1', 307)
('setup', 2)
('brca2', 7)
('hr', 71)
('-gtacttccagctagatgtt-3', 2)
('tata-binding', 2)
('peroxidase-conjugated', 2)
('knockdown', 25)
('representative', 8)
('bt549', 14)
('real-time', 2)
('line', 273)
('ber-proficient', 2)
('95', 10)
('than', 32)
('p53', 9)
('supp\\.', 6)
('10', 28)
('13', 17)
('12', 14)
('14', 49)
('these', 35)
('cells', 142)
('mtt', 44)
('sum1315mo2', 10)
('mammalian', 2)
('hcc1806', 14)
('cdna', 4)
('hogg1', 115)
('ber', 236)
('iqd', 52)
('taqman', 6)
('750', 2)
('rtqpcr', 4)
('150', 10)
('30', 8)
('estrogen', 2)
('figure', 18)
('vehicle-control', 6)
('brca1-wild-type', 4)
('endonuclease', 4)
('binding', 4)
('550', 4)
('0\\.01\\.', 4)
('\\*\\*', 12)
('sum149pt', 20)
('epithelial', 4)
('r\\=0\\.96', 4)
('mdamb361', 14)
('logarithmically-growing', 2)
('protein', 19)
('p\\=0\\.02', 4)
('80', 30)
('fpg', 10)
('nhej', 3)
('4a-b', 2)
('anti-brca1', 2)
('0\\.0007', 2)
('-', 780)
('40', 8)
('1', 759)
('mix', 4)
('5', 242)
('tbp', 2)
('333', 6)
('p\\=0\\.6', 4)
('hs578t', 8)
('normal-like', 24)
('200', 2)
('heterogeneous', 3)
('140', 4)
('sum1315mo2\\.', 2)
('sequence', 6)
('m', 1617)
('polymerase', 3)
('lymphoblast-derived', 2)
('71', 2)
('mdamb468\\.', 2)
('-mutated', 71)
('antibodies', 2)
('enzymes', 1)
('odd-induced', 10)
('lines', 195)
('or', 606)
('p53\\.', 2)
('assay\\.', 52)
('0\\.0094', 2)
('bt474', 18)
('4b', 4)
('4c', 8)
('50', 108)


spacy + metamap: 575('limited', 4)
('lack', 6)
('ge', 357)
('gc', 15)
('primer', 2)
('relationships', 2)
('amplification', 2)
('epithelial cells', 4)
('graph', 4)
('cycling', 2)
('recurrence', 1)
('tail', 18)
('repair endonuclease', 2)
('cm2', 2)
('transversion', 1)
('adenoviral', 4)
('assay', 92)
('risk', 2)
('her2\\/neu', 3)
('replication', 3)
('figs', 12)
('cellular', 12)
('difference', 16)
('multiple', 5)
('strand', 14)
('progression', 3)
('deficient', 30)
('adenovirus', 6)
('cell lines', 195)
('findings', 2)
('ovarian cancer', 2)
('fold', 32)
('dna repair', 15)
('her2', 7)
('bacterial', 2)
('odd', 149)
('sub', 85)
('cell', 427)
('template', 2)
('3c', 6)
('3b', 6)
('increasing', 16)
('ner', 16)
('method', 15)
('synthetic', 2)
('proliferation', 1)
('box plot', 4)
('alkaline', 12)
('genes', 22)
('triple-negative breast cancers', 2)
('understanding', 2)
('hours', 16)
('simon', 2)
('oxidative', 33)
('based', 24)
('alkaline comet assay', 10)
('dividing', 10)
('study', 9)
('larger', 2)
('reports', 4)
('highly statistically significant', 2)
('reagents', 6)
('pathways', 14)
('gene', 101)
('studies', 2)
('pathological', 7)
('vic', 2)
('family', 1)
('egfr', 1)
('regimens', 1)
('total', 2)
('aberrant', 6)
('environment', 4)
('conventional', 1)
('dna', 85)
('positive', 8)
('reporter gene', 42)
('enzyme', 13)
('process', 5)
('vehicle', 6)
('panel', 12)
('homologous recombination', 1)
('more', 53)
('0\\%', 2)
('populations', 2)
('infection', 10)
('non-target', 12)
('agent', 24)
('known', 16)
('high', 7)
('non-dividing cell', 4)
('ml', 2)
('setup', 2)
('human breast cancer cells', 2)
('endogenous', 5)
('values', 22)
('cdna', 4)
('strategies', 5)
('inhibitor', 35)
('example', 4)
('control', 56)
('indicated', 14)
('calculation', 12)
('endonuclease', 4)
('purposes', 4)
('spectrophotometry', 2)
('sample', 4)
('western blot', 8)
('association', 4)
('information', 2)
('redundancy', 4)
('defective', 32)
('initiate', 2)
('discussion', 2)
('damage', 72)
('lesions', 12)
('nucleotide excision repair', 1)
('pathway', 27)
('dna damage', 26)
('lesion', 13)
('derived', 2)
('concentrations', 14)
('dose-response curve', 8)
('data', 35)
('response', 51)
('types', 41)
('overexpression', 3)
('enzymes', 1)
('intact cell', 4)
('carriers', 6)
('lines', 195)
('brca1 mutation', 6)
('green', 6)
('shade', 4)
('healthcare', 6)
('typical', 7)
('shrna', 48)
('cancer prevention', 2)
('gene transfer', 4)
('crosstalk', 4)
('vector control', 2)
('feature', 1)
('50\\%', 2)
('experiments', 14)
('hydrogen peroxide', 2)
('combination therapies', 2)
('parameters', 8)
('lymphoblast', 2)
('p-value', 8)
('h2o2', 144)
('23', 12)
('pcr', 12)
('exact', 2)
('therapeutic effectiveness', 2)
('methodology', 2)
('better', 5)
('fold difference', 8)
('fig', 116)
('decreased', 18)
('dmso', 2)
('triple-negative breast cancer', 14)
('non-homologous end-joining', 1)
('non', 23)
('greater', 30)
('break', 10)
('tails', 10)
('type cell', 4)
('primary cancer cells', 2)
('1b', 6)
('horseradish peroxidase', 2)
('instructions', 4)
('susceptibility', 6)
('pbs', 2)
('proteins', 5)
('2d', 6)
('2b', 6)
('interpolation', 2)
('decreasing', 2)
('mean', 4)
('profile', 11)
('generation', 4)
('gfp', 92)
('parp-1', 1)
('deficiency', 16)
('lysis', 22)
('event', 11)
('er', 1162)
('living', 6)
('malignancies', 2)
('increase', 22)
('mediated', 14)
('reader', 4)
('newly', 2)
('induced', 16)
('pathologic', 8)
('linear', 14)
('tables', 2)
('ecl', 8)
('mechanisms', 5)
('mms', 22)
('approaches', 3)
('base', 39)
('formation', 6)
('mutation carrier', 4)
('additional', 2)
('dna repair protein', 1)
('interaction', 2)
('r2', 17)
('turn', 1)
('lethal', 2)
('r-', 13)
('therapeutic use', 1)
('1 minute', 2)
('cancer susceptibility gene', 4)
('top', 16)
('first', 13)
('major', 4)
('variables', 2)
('number', 4)
('one', 13)
('defects', 11)
('ionizing radiation', 2)
('specificity', 4)
('mammary', 2)
('little', 5)
('heads', 2)
('genotype', 4)
('introduction', 1)
('glycosylase', 7)
('system', 5)
('construct', 2)
('1a', 22)
('regulation', 4)
('intermediate', 3)
('master', 2)
('compromise', 14)
('percentage', 8)
('molecular', 1)
('brca1', 307)
('2-3', 2)
('brca2', 7)
('relationship', 18)
('minute', 8)
('basal', 123)
('chemicals', 4)
('part', 12)
('parp', 73)
('white', 2)
('p53', 9)
('30 seconds', 2)
('relative', 24)
('target', 24)
('double', 7)
('grey', 4)
('mutagenesis', 1)
('patients', 2)
('individual', 4)
('strand breaks', 4)
('ber', 236)
('lysate', 2)
('treated', 16)
('mini', 8)
('defect', 64)
('dash', 4)
('western blotting', 4)
('further', 17)
('need', 9)
('concentration', 22)
('null', 2)
('8-oxoguanine', 8)
('reverse transcription', 2)
('efficient', 16)
('transcription', 8)
('breast cancers', 29)
('mix', 4)
('potential', 4)
('objective', 6)
('optical density', 4)
('hereditary breast cancer', 2)
('t-distribution', 2)
('altered', 6)
('supplementary material', 2)
('normal', 31)
('correlation', 12)
('wells', 2)
('most', 1)
('mitomycin c', 1)
('aggressive clinical course', 1)
('average', 44)
('linear regression', 6)
('nonspecific', 4)
('dna repair enzyme', 4)
('sigma', 4)
('mtt assay', 38)
('text', 2)
('probe', 6)
('8-oxoguanine dna glycosylase', 1)
('threshold', 2)
('carcinogen', 18)
('aggressive', 3)
('isogenic', 14)
('current', 8)
('indicator', 12)
('targeted therapy', 2)
('ratio', 36)
('northern', 4)
('mammalian cell', 2)
('only', 1)
('bases', 8)
('black', 2)
('lipids', 4)
('population', 6)
('\\/ml', 2)
('normal breast', 6)
('plate', 14)
('ribosomal rna', 2)
('morphological', 1)
('greater than', 2)
('breast', 210)
('secondary', 2)
('blue light', 2)
('rna expression', 6)
('bar', 8)
('tumors', 5)
('cytotoxic chemotherapy', 1)
('median', 4)
('alteration', 5)
('summary', 2)
('subtype', 69)
('common', 5)
('activity', 64)
('cycles', 2)
('requirement', 4)
('set', 5)
('biological processes', 1)
('sensitivity', 177)
('coding sequence', 6)
('detection', 10)
('cytoplasmic', 2)
('result', 25)
('estrogen receptor', 2)
('mediators', 1)
('sporadic', 1)
('oncogene', 2)
('nuclear', 12)
('transcriptional regulation', 2)
('inhibitors', 11)
('tumor suppressor', 3)
('future', 4)
('various', 2)
('membrane', 2)
('reading', 6)
('sensitivities', 2)
('variability', 6)
('oxidize', 8)
('gene expression profiling', 1)
('ability', 23)
('parental', 2)
('targeted', 4)
('quadruplicate', 6)
('efficiency', 4)
('subgroup', 2)
('oxidizing agent', 2)
('reaction', 4)
('improved', 1)
('minutes', 4)
('pdt', 8)
('equal', 2)
('drug', 5)
('sensitive', 65)
('negative', 34)
('comet', 40)
('expression', 97)
('cancer', 192)
('point', 4)
('removal', 4)
('period', 2)
('pol', 11)
('table', 30)
('ct', 387)
('pr', 316)
('progesterone receptor', 2)
('addition', 4)
('three', 16)
('extraction', 2)
('r\\.', 48)
('initiation', 3)
('maintenance', 1)
('basic', 4)
('cytogenetic abnormalities', 1)
('drugs', 1)
('metastasis', 1)
('sufficient', 4)
('24 hours', 4)
('readings', 2)
('determination', 2)
('representative', 8)
('applied', 2)
('novel', 18)
('solid', 4)
('value', 60)
('near', 22)
('genomic stability', 4)
('hogg1', 115)
('wild', 36)
('poor prognosis', 1)
('mutant', 16)
('characteristics', 1)
('statistical analysis', 2)
('triple', 34)
('breast cancer cell', 99)
('protein', 19)
('different', 34)
('clinical trials', 2)
('radiation', 3)
('elevated', 8)
('phenotype', 2)
('plates', 4)
('several', 4)
('events', 2)
('higher', 2)
('status', 11)
('independent', 14)
('attenuation', 3)
('effect', 11)
('kit', 4)
('levels', 32)
('student', 4)
('immunohistochemical', 1)
('robust', 4)
('dna damage response', 6)
('antibodies', 2)
('genome instability', 2)
('scenario', 2)
('tata-binding protein', 2)
('gene expression profile', 4)
('well', 16)
('analysis', 20)
('options', 1)
('patterns', 1)
('materials', 5)
('therapy', 5)
('left', 3)
('ic50', 72)
('excessive', 2)
('less', 8)
('observed', 14)
('shape', 2)
('mechanism', 13)
('human', 11)
('previous', 14)
('visualization', 4)
('loading', 2)
('vivo', 8)
('majority', 2)
('ease', 65)
('human cells', 1)
('horseradish', 2)
('conjugated', 2)
('treatment', 21)
('sensitive population', 2)
('transformation', 2)
('murine', 2)
('increased', 10)
('rna', 61)
('mutations', 15)
('dark', 2)
('finding', 12)
('72 hours', 4)
('inhibition', 43)
('atcc', 2)
('background', 6)
('loss', 4)
('signal', 4)
('mrna expression', 4)
('mcf7', 86)
('specific', 26)
('benefit', 3)
('steps', 4)
('decrease', 34)
('essential', 1)
('a t', 30)
('therapeutic', 17)
('methods', 5)
('luminal', 60)
('heterogeneous disease', 1)
('cell line', 237)
('subtypes', 35)
('intact', 8)
('lead', 9)
('alkaline comet', 10)
('broad', 2)
('pathogenesis', 2)
('retro', 2)
('forks', 1)
('gene expression', 6)
('scientific', 4)
('parp inhibitors', 8)
('10 minutes', 2)
('use', 17)
('fluorescent', 24)
('fluorescent microscopy', 12)
('manufacturer', 4)
('comparison', 2)
('bars', 2)
('carcinogenesis', 16)
('statistically significant', 4)
('reactive oxygen species', 1)
('reduced', 2)
('range', 8)
('tailed', 2)
('confidence interval', 2)
('antibody', 4)
('software', 8)
('presence', 24)
('parp inhibitor', 30)
('image', 2)
('two', 28)
('appropriate', 2)
('genetic backgrounds', 2)
('systemic treatment', 1)
('pvdf', 2)
('log', 23)
('area', 4)
('approximate', 8)
('mutated', 73)
('clinical', 6)
('breast cancer', 171)
('metabolism', 1)
('synthesis', 2)
('function', 14)
('fragmented', 2)
('head', 2)
('delivery', 8)
('line', 273)
('mcf7 cells', 2)
('supp', 19)
('cells', 142)
('brca1 mutation carrier', 2)
('up', 39)
('mtt', 44)
('genomic instability', 2)
('oxidative stress', 6)
('cancers', 40)
('heterogeneous', 3)
('distribution', 2)
('similar', 32)
('clear', 18)
('complicated', 2)
('regression analysis', 10)
('universal', 2)
('condition', 8)
('al', 618)
('exogenous', 4)
('single', 5)
('crystals', 4)
('functions', 5)
('nhej', 3)
('corporation', 2)
('ne', 575)
('setting', 1)
('role', 17)
('test', 12)
('dna repair pathway', 4)
('bottom', 8)
('important', 6)
('mitotic index', 1)
('variable', 4)
('fisher', 2)
('increased sensitivity', 4)
('fluorescence', 4)
('described', 16)
('mitochondria', 2)
('time', 12)
('4a', 8)


total: 746('limited', 4)
('all', 41)
('lack', 6)
('mdamb468', 14)
('ge', 357)
('gc', 15)
('primer', 2)
('relationships', 2)
('amplification', 2)
('epithelial cells', 4)
('graph', 4)
('white', 2)
('non-dividing', 4)
('cycling', 2)
('recurrence', 1)
('0', 535)
('tail', 18)
('repair endonuclease', 2)
('cm2', 2)
('cdna', 4)
('adenoviral', 4)
('assay', 92)
('risk', 2)
('her2\\/neu', 3)
('replication', 3)
('odd-induced', 10)
('cellular', 12)
('difference', 16)
('exact', 2)
('strand', 14)
('mmecs', 46)
('progression', 3)
('deficient', 30)
('ecl', 8)
('progesterone', 2)
('p', 1671)
('-cgatgttgttgttggaggaac-3', 2)
('further', 17)
('adenovirus', 6)
('cell lines', 195)
('findings', 2)
('ovarian cancer', 2)
('192', 2)
('fold', 32)
('dna repair', 15)
('her2', 7)
('bacterial', 2)
('odd', 149)
('sub', 85)
('cell', 427)
('template', 2)
('3c', 6)
('values', 22)
('photodynamic', 2)
('ner', 16)
('method', 15)
('synthetic', 2)
('proliferation', 1)
('box plot', 4)
('reporter', 42)
('alkaline', 12)
('hogg1-knockdown', 16)
('genes', 22)
('triple-negative breast cancers', 2)
('understanding', 2)
('hours', 16)
('shape', 2)
('simon', 2)
('oxidative', 33)
('based', 24)
('100', 6)
('alkaline comet assay', 10)
('solid', 4)
('39', 2)
('38', 24)
('brca1-deficient', 13)
('dividing', 10)
('study', 9)
('30', 8)
('37', 14)
('reports', 4)
('highly statistically significant', 2)
('reagents', 6)
('gene', 101)
('studies', 2)
('pathological', 7)
('\\/sub', 4)
('rtqpcr', 4)
('family', 1)
('egfr', 1)
('333', 6)
('mutant', 16)
('regimens', 1)
('0\\.0981', 2)
('fluorescent', 24)
('total', 2)
('aberrant', 6)
('environment', 4)
('conventional', 1)
('dna', 85)
('indicated', 14)
('gfp-reporter', 8)
('reporter gene', 42)
('anti-tata', 2)
('only', 1)
('process', 5)
('10ng', 2)
('6', 133)
('mcf7shctrl', 20)
('panel', 12)
('ber-compromised', 6)
('homologous recombination', 1)
('more', 53)
('0\\%', 2)
('populations', 2)
('mitotic index', 1)
('550', 4)
('non-target', 12)
('spectrophotometry', 2)
('real-time', 2)
('known', 16)
('95', 10)
('potential', 4)
('supp\\.', 6)
('sample', 4)
('non-dividing cell', 4)
('ml', 2)
('setup', 2)
('human breast cancer cells', 2)
('endogenous', 5)
('mammalian', 2)
('hcc1806', 14)
('transversion', 1)
('strategies', 5)
('inhibitor', 35)
('example', 4)
('control', 56)
('figure', 18)
('vehicle-control', 6)
('calculation', 12)
('endonuclease', 4)
('purposes', 4)
('agent', 24)
('high', 7)
('western blot', 8)
('association', 4)
('information', 2)
('fpg', 10)
('redundancy', 4)
('defective', 32)
('initiate', 2)
('0\\.0007', 2)
('feature', 1)
('0\\.0003', 14)
('1', 759)
('lesions', 12)
('hogg1-', 70)
('nucleotide excision repair', 1)
('pathway', 27)
('profile', 11)
('lesion', 13)
('140', 4)
('sum1315mo2\\.', 2)
('use', 17)
('derived', 2)
('polymerase', 3)
('dose-response curve', 8)
('data', 35)
('response', 51)
('types', 41)
('overexpression', 3)
('enzymes', 1)
('intact cell', 4)
('carriers', 6)
('brca1-wild-type', 4)
('brca1 mutation', 6)
('green', 6)
('increasing', 16)
('0\\.0094', 2)
('healthcare', 6)
('discussion', 2)
('figs', 12)
('shrna', 48)
('cancer prevention', 2)
('repair', 97)
('gene transfer', 4)
('crosstalk', 4)
('vector control', 2)
('damage', 72)
('experiments', 14)
('hydrogen peroxide', 2)
('combination therapies', 2)
('parameters', 8)
('-gtatggacactgactcaga-3', 2)
('lymphoblast', 2)
('p-value', 8)
('20', 13)
('h2o2', 144)
('ber-defective', 2)
('23', 12)
('pcr', 12)
('therapeutic effectiveness', 2)
('29', 8)
('better', 5)
('fold difference', 8)
('condition', 8)
('decreased', 18)
('dmso', 2)
('suppressor', 3)
('non-homologous end-joining', 1)
('non', 23)
('greater', 30)
('hcc38', 20)
('fig', 116)
('number', 4)
('break', 10)
('tails', 10)
('type cell', 4)
('primary cancer cells', 2)
('1b', 6)
('horseradish peroxidase', 2)
('instructions', 4)
('puromycin\\.', 2)
('pbs', 2)
('proteins', 5)
('events', 2)
('2d', 6)
('2a', 22)
('2b', 6)
('each', 45)
('interpolation', 2)
('decreasing', 2)
('t47d\\.', 2)
('typical', 7)
('minute', 8)
('dna damage', 26)
('-tgccaaagtagctaatgta-3', 2)
('250nm', 2)
('generation', 4)
('gfp', 92)
('parp-1', 1)
('700', 2)
('t47d', 14)
('900nm', 2)
('brca1\\.', 10)
('wild-type', 36)
('lysis', 22)
('80', 30)
('87', 2)
('er', 1162)
('living', 6)
('malignancies', 2)
('increase', 22)
('contained', 8)
('mediated', 14)
('hcc1937', 8)
('reader', 4)
('newly', 2)
('induced', 16)
('pvdf', 2)
('linear', 14)
('tables', 2)
('-ggctagacctccaagatca-3', 2)
('mechanisms', 5)
('little', 5)
('mms', 22)
('approaches', 3)
('base', 39)
('formation', 6)
('intermediate', 3)
('mutation carrier', 4)
('additional', 2)
('dna repair protein', 1)
('interaction', 2)
('r2', 17)
('turn', 1)
('lethal', 2)
('target', 24)
('r-', 13)
('therapeutic use', 1)
('1 minute', 2)
('cancer susceptibility gene', 4)
('top', 16)
('first', 13)
('major', 4)
('variables', 2)
('coding', 6)
('primary', 2)
('one', 13)
('defects', 11)
('ionizing radiation', 2)
('specificity', 4)
('177', 2)
('mammary', 2)
('taqman\xc2\xae', 2)
('heads', 2)
('genotype', 4)
('introduction', 1)
('glycosylase', 7)
('system', 5)
('construct', 2)
('1a', 22)
('regulation', 4)
('2', 502)
('master', 2)
('basal-like', 113)
('compromise', 14)
('percentage', 8)
('molecular', 1)
('brca1', 307)
('2-3', 2)
('brca2', 7)
('relationship', 18)
('-gtacttccagctagatgtt-3', 2)
('tata-binding', 2)
('peroxidase-conjugated', 2)
('basal', 123)
('chemicals', 4)
('part', 12)
('parp', 73)
('ber-proficient', 2)
('than', 32)
('p53', 9)
('30 seconds', 2)
('10', 28)
('13', 17)
('12', 14)
('14', 49)
('double', 7)
('grey', 4)
('mutagenesis', 1)
('patients', 2)
('cytoplasmic', 2)
('methodology', 2)
('strand breaks', 4)
('ber', 236)
('lysate', 2)
('treated', 16)
('and', 534)
('mini', 8)
('gene expression profile', 4)
('lines', 195)
('defect', 64)
('dash', 4)
('western blotting', 4)
('r\\=0\\.96', 4)
('mdamb361', 14)
('need', 9)
('concentration', 22)
('null', 2)
('8-oxoguanine', 8)
('reverse transcription', 2)
('efficient', 16)
('\\*\\*', 12)
('-', 780)
('breast cancers', 29)
('majority', 2)
('materials', 5)
('325', 2)
('objective', 6)
('optical density', 4)
('hereditary breast cancer', 2)
('normal-like', 24)
('200', 2)
('multiple', 5)
('shade', 4)
('supplementary material', 2)
('normal', 31)
('correlation', 12)
('wells', 2)
('76', 2)
('71', 2)
('mitomycin c', 1)
('mdamb468\\.', 2)
('-mutated', 71)
('aggressive clinical course', 1)
('average', 44)
('m', 1617)
('linear regression', 6)
('nonspecific', 4)
('dna repair enzyme', 4)
('sigma', 4)
('mtt assay', 38)
('text', 2)
('detection', 10)
('probe', 6)
('fpg-induced', 2)
('8-oxoguanine dna glycosylase', 1)
('threshold', 2)
('carcinogen', 18)
('aggressive', 3)
('adp-ribose', 4)
('isogenic', 14)
('current', 8)
('indicator', 12)
('targeted therapy', 2)
('ratio', 36)
('northern', 4)
('less', 8)
('mammalian cell', 2)
('enzyme', 13)
('bases', 8)
('black', 2)
('lipids', 4)
('population', 6)
('\\/ml', 2)
('normal breast', 6)
('plate', 14)
('ribosomal rna', 2)
('tbp', 2)
('morphological', 1)
('greater than', 2)
('breast', 210)
('3b', 6)
('129', 2)
('t-distribution', 2)
('secondary', 2)
('blue light', 2)
('rna expression', 6)
('bar', 8)
('tumors', 5)
('cytotoxic chemotherapy', 1)
('median', 4)
('alteration', 5)
('summary', 2)
('receptor-', 2)
('subtype', 69)
('common', 5)
('activity', 64)
('cycles', 2)
('requirement', 4)
('set', 5)
('biological processes', 1)
('sensitivity', 177)
('coding sequence', 6)
('relative', 24)
('individual', 4)
('result', 25)
('estrogen receptor', 2)
('mediators', 1)
('sporadic', 1)
('lines\\.', 10)
('oncogene', 2)
('antibody\\.', 2)
('exogenous', 4)
('nuclear', 12)
('transcriptional regulation', 2)
('inhibitors', 11)
('tumor suppressor', 3)
('3', 240)
('future', 4)
('various', 2)
('membrane', 2)
('367', 2)
('reading', 6)
('sensitivities', 2)
('variability', 6)
('bt549', 14)
('gene expression profiling', 1)
('ability', 23)
('parental', 2)
('targeted', 4)
('quadruplicate', 6)
('mdamb436', 8)
('-ggagatcagccattaatat-3', 2)
('subgroup', 2)
('oxidizing agent', 2)
('reaction', 4)
('improved', 1)
('fig\\.', 82)
('taqman', 6)
('hcc1500', 8)
('equal', 2)
('drug', 5)
('sensitive', 65)
('figures', 2)
('comet', 40)
('expression', 97)
('ease', 65)
('positive', 8)
('cancer', 192)
('point', 4)
('removal', 4)
('mutations', 15)
('poly', 7)
('pol', 11)
('63', 2)
('table', 30)
('mcf12a', 8)
('ct', 387)
('pr', 316)
('progesterone receptor', 2)
('vivo', 8)
('addition', 4)
('three', 16)
('extraction', 2)
('r\\.', 48)
('initiation', 3)
('maintenance', 1)
('basic', 4)
('sum1315mo2', 10)
('500', 10)
('treatment', 21)
('cytogenetic abnormalities', 1)
('drugs', 1)
('sufficient', 4)
('confidence interval', 2)
('readings', 2)
('determination', 2)
('representative', 8)
('sensitive population', 2)
('altered', 6)
('applied', 2)
('novel', 18)
('these', 35)
('triple-negative breast cancer', 14)
('value', 60)
('near', 22)
('genomic stability', 4)
('hogg1', 115)
('wild', 36)
('poor prognosis', 1)
('pdt', 8)
('characteristics', 1)
('binding', 4)
('sum149pt', 20)
('statistical analysis', 2)
('triple', 34)
('breast cancer cell', 99)
('protein', 19)
('different', 34)
('clinical trials', 2)
('4a-b', 2)
('radiation', 3)
('elevated', 8)
('phenotype', 2)
('plates', 4)
('several', 4)
('p\\=0\\.6', 4)
('higher', 2)
('status', 11)
('independent', 14)
('attenuation', 3)
('effect', 11)
('kit', 4)
('levels', 32)
('two', 28)
('student', 4)
('immunohistochemical', 1)
('robust', 4)
('dna damage response', 6)
('antibodies', 2)
('genome instability', 2)
('scenario', 2)
('tata-binding protein', 2)
('nhej', 3)
('well', 16)
('analysis', 20)
('options', 1)
('patterns', 1)
('p53\\.', 2)
('transcription', 8)
('therapy', 5)
('left', 3)
('ic50', 72)
('excessive', 2)
('background', 6)
('vic', 2)
('observed', 14)
('-cgacaagaccccatcgaatgccttttc-3', 2)
('50\\%', 2)
('mechanism', 13)
('human', 11)
('ribosomal', 2)
('previous', 14)
('visualization', 4)
('loading', 2)
('odd-specific', 10)
('signal', 4)
('mix', 4)
('\\?', 93)
('\\<', 16)
('human cells', 1)
('horseradish', 2)
('conjugated', 2)
('oxidatively-damaged', 8)
('\\.', 864)
('5', 242)
('transformation', 2)
('\\(', 451)
('\\)', 463)
('murine', 2)
('logarithmically-growing', 2)
('increased', 10)
('susceptibility', 6)
('rna', 61)
('brca2-deficient', 1)
('period', 2)
('dark', 2)
('finding', 12)
('72 hours', 4)
('inhibition', 43)
('atcc', 2)
('265', 2)
('loss', 4)
('58', 8)
('efficiency', 4)
('mrna expression', 4)
('mcf7', 86)
('specific', 26)
('benefit', 3)
('lymphoblast-derived', 2)
('decrease', 34)
('essential', 1)
('a t', 30)
('therapeutic', 17)
('methods', 5)
('luminal', 60)
('heterogeneous disease', 1)
('cell line', 237)
('50', 108)
('subtypes', 35)
('intact', 8)
('anti-brca1', 2)
('lead', 9)
('alkaline comet', 10)
('broad', 2)
('pathogenesis', 2)
('mcf7shogg1-a', 22)
('retro', 2)
('mcf7shogg1-b', 22)
('steps', 4)
('forks', 1)
('gene expression', 6)
('scientific', 4)
('parp inhibitors', 8)
('10 minutes', 2)
('mdamb231', 8)
('brca1-', 26)
('g\\/ml', 2)
('fluorescent microscopy', 12)
('manufacturer', 4)
('comparison', 2)
('bars', 2)
('most', 1)
('carcinogenesis', 16)
('statistically significant', 4)
('reactive oxygen species', 1)
('reduced', 2)
('tumor', 10)
('range', 8)
('infection', 10)
('tailed', 2)
('concentrations', 14)
('mean', 4)
('antibody', 4)
('or', 606)
('software', 8)
('brca1-mutated', 8)
('presence', 24)
('parp inhibitor', 30)
('image', 2)
('negative', 34)
('appropriate', 2)
('receptor', 4)
('genetic backgrounds', 2)
('hcc1143', 18)
('systemic treatment', 1)
('pathologic', 8)
('bt474', 18)
('log', 23)
('area', 4)
('sequence', 6)
('approximate', 8)
('mutated', 73)
('clinical', 6)
('hs578t', 8)
('breast cancer', 171)
('metabolism', 1)
('synthesis', 2)
('function', 14)
('fragmented', 2)
('head', 2)
('750', 2)
('hr', 71)
('vehicle', 6)
('delivery', 8)
('knockdown', 25)
('larger', 2)
('line', 273)
('triple-negative', 34)
('mcf7 cells', 2)
('deficiency', 16)
('supp', 19)
('cells', 142)
('brca1 mutation carrier', 2)
('up', 39)
('mtt', 44)
('genomic instability', 2)
('oxidative stress', 6)
('cancers', 40)
('\xc2\xb1', 92)
('heterogeneous', 3)
('iqd', 52)
('distribution', 2)
('similar', 32)
('clear', 18)
('150', 10)
('estrogen', 2)
('oxidize', 8)
('complicated', 2)
('regression analysis', 10)
('minutes', 4)
('universal', 2)
('metastasis', 1)
('al', 618)
('0\\.01\\.', 4)
('single', 5)
('epithelial', 4)
('crystals', 4)
('p\\=0\\.02', 4)
('functions', 5)
('49', 38)
('corporation', 2)
('ne', 575)
('40', 8)
('event', 11)
('setting', 1)
('role', 17)
('test', 12)
('24 hours', 4)
('dna repair pathway', 4)
('bottom', 8)
('important', 6)
('pathways', 14)
('variable', 4)
('fisher', 2)
('increased sensitivity', 4)
('fluorescence', 4)
('described', 16)
('mitochondria', 2)
('assay\\.', 52)
('time', 12)
('4b', 4)
('4c', 8)
('4a', 8)
